Opportunities / HEALTH AND HUMAN SERVICES, DEPARTMENT OF
FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
| Notice type | Special Notice |
|---|---|
| Solicitation # | FDABAA-27-00123 |
| Department | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Sub-tier / office | FOOD AND DRUG ADMINISTRATION / FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AJ11 |
| Set-aside | No set-aside |
| Posted | Oct 30, 2026 |
| Response deadline | Jan 22, 2027 (2027-01-22T17:00:00-05:00) |
| Place of performance | — |
| Primary contact | Ian Weiss · Ian.Weiss@fda.hhs.gov · 3017965728 |
Description (excerpt)
Amendment 001 - 10/30/26 - Updated the proposal due date from 2/1/27 at 5:00 pm to 1/22/27 at 5:00 pm. Updated the Special Notice Archive date from 15 days after response date to 09/30/27. In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement. FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation.